CAS 132628-16-1: N-(2-Phenylacetyl)guanosine

N2-Phenylacetylguanosine is a compound that has shown potential in the treatment of erectile dysfunction and emissions. It is commonly used as an advanced intermediate in the synthesis of various pharmaceuticals, including monoclonal antibodies like imatinib. N2-Phenylacetylguanosine has also been studied for its role in fatty acid metabolism and its ability to inhibit the plpro enzyme. Additionally, it has shown promise as a neutralizing agent against certain strains of coronaviruses in human trials. This compound is not only relevant to the medical field but also finds applications in agriculture as it can be used as an ingredient in herbicides. N2-Phenylacetylguanosine shares similarities with sildenafil, a well-known medication for erectile dysfunction, making it an interesting subject for further research and development.

N2-Phenylacetyl Guanosine

N2-Phenylacetylguanosine is a novel, modified ribonucleoside with anticancer and antiviral activities. It can be used as a monophosphate or diphosphate. N2-Phenylacetylguanosine is synthesized from 2-phenylethylamine and guanosine using phosphoramidite chemistry. It has been shown to activate DNA synthesis and cell proliferation in vitro, which may lead to tumor growth inhibition.